Send feedback

SPAST p.Pro45=

c.135G>A · rs757100197 · VCV1136353

Likely benign Single submitter
Classification
Likely benign
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
gnomAD v4.1
Rare
very rare (popmax 8.48e-05%, nfe)
Conditions
1
hereditary spastic paraplegia 4

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 3.8GERP -0.16, phastCons 1
Overall
CADD13.12PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 8.48e-05% European (non-Finnish) · 1/1,178,958 alleles
Overall 0.000124% 2/1,612,094 alleles · very rare exomes 2/1,459,954 · genomes 0/152,140 · joint denominator
Ancestry group Frequency 1 in
Finnishnot grpmax-eligible 0.00157% 63,862
European (non-Finnish)grpmax 8.48e-05% 1,178,957

Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
SPAST
Protein
p.Pro45=
Coding
c.135G>A
MANE Select
NM_014946
dbSNP
rs757100197
Type
single nucleotide variant
Location
chr2:32063966 (GRCh38)
Gene constraint
LOEUF 0.69 · pLI 0.11 · ClinGen HI 3/3 (gnomAD)
Structure
AlphaFold pLDDT 77.03 · 7 PDB
Residue 45
a UniProt-annotated variant site (in spg4); a UniProt-annotated variant site (acts as a disease modifier; patients carrying a mutated allele of spastin and q-45 on the other allele are affected by severe spastic paraplegia with an early age of onset); the 'required for interaction with rtn1' region; the 'required for midbody localization' region; the 'required for interaction with atl1' region; the 'required for nuclear localization' region
Full SPAST gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

hereditary spastic paraplegia 4 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Autosomal dominant spastic paraplegia type 4 (Orphanet):

Inheritance
Autosomal dominant
Onset
Adolescent, Adult, Childhood, Infancy
Prevalence
1-9 / 1 000 000 (Portugal)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/spast-p-pro45 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown